Department Of Digestive & Liver Diseases
Investigator
Elizabeth Verna, MD
Email
ev77@cumc.columbia.edu

Dr. Elizabeth C. Verna manages patients with a variety of liver diseases. Her clinical interests focus on viral hepatitis and liver transplantation as well as the new emerging therapies for hepatitis C, liver cancer, alcoholic and non-alcoholic fatty liver disease and metabolic liver diseases. She also has expertise in the management of end stage liver disease and its complications.


Clinical Studies Managed By This Investigator:
Condition Study Title
Liver Transplant [ CLOSED ] Study for liver transplant recipients using drug (IgG) to prevent Hepatitis C virus (HCV) recurrence
Hepatitis [ CLOSED ] Study to Treat Patients With Chronic Hepatitis C Virus (HCV) Genotype 1 and End-Stage Renal Disease (ESRD) using trial drugs
Liver Transplant [ CLOSED ] A study for liver transplant patients with Chronic HCV using study drug Harvoni
Hepatitis [ CLOSED ] A study for patients with Chronic HCV Infection using study drugs Sofosbuvir, Velpatasvir and GS-9857
Hepatitis [ CLOSED ] A study for patients with Chronic HCV Infection using study drug combination Sofosbuvir/Velpatasvir/GS-9857
Hepatitis [ CLOSED ] A study for patients with Chronic Genotype 3 HCV Infection and Cirrhosis using study drugs Sofosbuvir, Velpatasvir and GS-9857
Liver Disease [ CLOSED ] A study for patients with Non-Alcoholic Steatohepatitis (NASH using study drug armachol
Hepatitis [ CLOSED ] A study for patients with Chronic HCV Infection who have not received an NS5A Inhibitor using study drugs Sofosbuvir/Velpatasvir/GS-9857
Hepatitis [ CLOSED ] A study for patients with chronic hepatitis C and advanced heart failure or lung disease using study drug Harvoni
NASH [ CLOSED ] Study of Emricasan in subjects with Non-Alcoholic Steatohepatitis (NASH) Cirrhosis
Liver Disease [ CLOSED ] GLIMMER: Study of Drug in Treatment of Pruritus (Itching) in Patients with Primary Biliary Cholangitis
Liver Cancer A 5-Year Study of the Natural History and Management of Patients with Hepatocellular Carcioma (A Type of Liver Cancer)
NASH [ CLOSED ] TARGET-NASH: Longitudinal Observational Study of Patients with Nonalcoholic Fatty Liver or Nonalcoholic Steatohepatitis
Hepatitis [ CLOSED ] THE PRIORITIZE STUDY: Study of Oral Regimens for Hepatitis C
Hepatitis An Observational Study of Patients Undergoing Therapy for Chronic Hepatitis B (HBV) Infection
Liver Disease [ CLOSED ] Study of seladelpar in subjects with primary biliary cholangitis (PBC)
Liver Disease Registry Study of Adult Patients with Primary Sclerosing Cholangitis (PSC)
Transplant [ CLOSED ] Prevention of Hepatitis C with Antiviral HCV Therapy After Liver and/or Kidney Transplant
Cirrhosis of the Liver Red-C 3131: Study of Rifaximin in Preventing Hepatic Encephalopathy (HE) in Patients with Advanced Liver Cirrhosis
Liver Disease Advancing Liver Therapeutic Approaches (ALTA) in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunt (TIPS)